Sandi See Tai

Sandi See Tai has a wealth of experience in the pharmaceutical and medical field, with a focus on rare diseases, transplantation, and pediatric nephrology. Currently serving as the Chief Development Officer at Lexeo Therapeutics, Sandi previously held leadership positions at Pfizer and Wyeth Pharmaceuticals. With a background in medicine and a strong track record in clinical development and operations, Sandi brings a unique blend of expertise to the healthcare industry.